Low barrier medication for opioid use disorder at a federally qualified health center: a retrospective cohort study

Low barrier medication for opioid use disorder at a federally qualified health center: a retrospective cohort study

Abstract Background Medication for opioid use disorder (MOUD) reduces mortality, but few patients access MOUD. At a Federally Qualified Health Center (FQHC), we implemented a low barrier model of MOUD, including same-day MOUD initiation and a harm reduction philosophy. Objective To investigate wheth...

Full description

Bibliographic Details
Main Authors: Jamie Carter, Zhen Li, Hillary Chen, Melissa Greiner, Christopher Bush, Debanjan Bhattacharya, Stephanie Poley, Nidhi Sachdeva, Jane Carolyn Crowder, Jacob Feigal
Format: Article
Language:English
Published: BMC 2022-11-01
Series:Addiction Science & Clinical Practice
Subjects:
Opioid use disorder
Medication for opioid use disorder
Buprenorphine
Harm reduction
Online Access:https://doi.org/10.1186/s13722-022-00342-1

Internet

https://doi.org/10.1186/s13722-022-00342-1

Similar Items